Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

v3.22.2
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
Total
Ordinary Shares Class A
Ordinary Shares Class B
Ordinary Shares
Ordinary Shares Class A
Ordinary Shares
Ordinary Shares Class B
Reserves
Subscription Receivable
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Total Stockholders' Equity (Virax)
Non Controlling Interest
Number of shares, beginning balance at Mar. 31, 2020       620,879 422,773            
Equity, beginning balance at Mar. 31, 2020 $ (1,215,124)     $ 62 $ 42 $ 2,920,018   $ (3,977,155) $ 937 $ (1,056,096) $ (159,028)
Settlement of fees due to a former SingaporeCo non- executive director, shares       25,717              
Settlement of fees due to a former SingaporeCo non- executive director 25,000     $ 3   24,997       25,000  
Shares issued for settlement of related party payable, shares       621,795              
Shares issued for settlement of related party payable 604,890     $ 62   604,828       604,890  
Shares issued for cash, shares       955,145              
Shares issued for cash 403,218     $ 96   457,619 $ (54,497)     403,218  
Issuance of Founder Shares, shares       7,547 6,577,166            
Issuance of Founder Shares       $ 1 $ 658 (659)          
Imputed interest 26,991         26,991       26,991  
Foreign currency adjustment (3,874)               (3,701) (3,701) (173)
Net Loss (672,915)             (650,984)   (650,984) (21,931)
Number of shares, ending balance at Mar. 31, 2021   2,223,083 6,999,939 2,231,083 6,999,939            
Equity, ending balance at Mar. 31, 2021 (831,814)     $ 224 $ 700 4,033,794 (54,497) (4,628,139) (2,764) (650,682) (181,132)
Shares issued for settlement of related party payable, shares       172,532              
Shares issued for settlement of related party payable 452,861     $ 17   452,844       452,861  
Shares issued for cash, shares       238,906              
Shares issued for cash 519,613     $ 24   519,589       519,613  
Shares issued for services, shares       319,536 26,820            
Shares issued for services 290,364     $ 32 $ 3 290,329       290,364  
Shares issued for conversion of convertible debt. shares       37,735              
Shares issued for conversion of convertible debt 100,000     $ 4   99,996       100,000  
Transfer of Class B to Class A, shares       83,000 (83,000)            
Transfer of Class B to Class A       $ 8 $ (8)            
Surrender of ViraxClear Shares, shares       (50,000)              
Surrender of ViraxClear Shares       $ (5)   (54,492) $ 54,497        
Imputed interest 21,128         21,128       21,128  
Foreign currency adjustment 1,010               965 965 45
Net Loss (1,749,870)             (1,708,827)   (1,708,827) (41,043)
Number of shares, ending balance at Mar. 31, 2022   3,032,792 6,943,759 3,032,792 6,943,759            
Equity, ending balance at Mar. 31, 2022 $ (1,196,708)     $ 304 $ 695 $ 5,363,188   $ (6,336,966) $ (1,799) $ (974,578) $ (222,130)